Testing a Ring-Shaped Blood Pressure Monitor in People With Heart Failure
Compares a wearable ring blood pressure device with standard 24-hour monitoring in heart failure.
Key facts
- Who runs it
- Keimyung University Dongsan Medical Center
- Where
- Daegu, South KoreaSee the site
- Trial code
- Registry title
- Feasibility and Effectiveness of a Ring-Type Blood Pressure Device (CART-BP) Compared With 24-Hour Ambulatory Blood Pressure Monitoring in HFrEF
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 23 Oct 2025
- Planned end
- 22 Oct 2026
- Type of study
- Observational
- Record updated
- 4 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with heart failure and a weak heart pump (LVEF 40% or lower). It compares a ring-type blood pressure device with a 24-hour blood pressure monitor.
- Age
- 19 years or older
- Sex
- All sexes can join
- Disease stage
- Heart failure under treatment, with left ventricular ejection fraction (LVEF) of 40% or lower, confirmed by echocardiography within 1 year before joining
- Earlier treatment
- Must be currently treated for heart failure
Main reasons for not taking part
- Office blood pressure outside these limits: top number below 90 or above 180 mmHg, bottom number below 50 or above 100 mmHg
- Cannot do 24-hour blood pressure monitoring
- Cannot wear or use the ring-type device
- Large differences between three resting blood pressure readings (20 mmHg or more for the top number, 10 mmHg or more for the bottom number)
- Pregnant, suspected pregnancy or breastfeeding
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age ≥ 19 years (male or female)
- Diagnosed with heart failure and currently under treatment
- Left ventricular ejection fraction (LVEF) ≤ 40% confirmed by echocardiography performed within 1 year prior to enrollment
- Able to undergo both 24-hour ambulatory blood pressure monitoring and ring-type blood pressure measurement
- Voluntarily provided written informed consent to participate in this clinical study
Who cannot take part
- Office blood pressure: SBP < 90 mmHg, or DBP < 50 mmHg, or SBP > 180 mmHg, or DBP > 100 mmHg
- Unable to perform 24-hour ambulatory blood pressure monitoring
- Unable to wear or use the ring-type blood pressure device
- Variability in three consecutive resting cuff blood pressure measurements ≥ 20 mmHg (SBP) or ≥ 10 mmHg (DBP)
- Insufficient valid ABPM readings: < 25 daytime or < 12 nighttime measurements per ESH criteria; or < 25 daytime or < 12 nighttime valid readings from the ring-type device
- Pregnant, suspected pregnancy, or breastfeeding
- Judged by the investigator to be legally or mentally unfit to participate in the clinical study
Where in South Korea
- Keimyung University - Dongsan Medical CenterDaegu, South KoreaContact: Hyemin KwonTaking people
About the trial
What the trial wants to find out
This study aims to evaluate the feasibility and diagnostic accuracy of the CART-BP ring-type wearable blood pressure monitoring device in comparison with 24-hour ambulatory blood pressure monitoring (ABPM) in patients with heart failure with reduced ejection fraction (HFrEF, LVEF ≤ 40%). As a multi-center, prospective, exploratory study, 100 patients will be enrolled at two tertiary hospitals in South Korea. The agreement between the two devices in 24-hour mean, daytime, and nighttime blood pressure measurements will be assessed per ISO 81060-2:2018 criteria.
The group in the trial
- Heart failure with reduced ejection fraction
Heart failure with reduced ejection fraction with or without hypertension
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility and Effectiveness of a RING-type Blood Pressure Measurement Device (CART-BP) Compared With 24-Hour Ambulatory Blood Pressure Monitoring Device in Patients With Heart Failure With Reduced Ejection Fraction (RING-HFrEF)
- Plain-language title
- Testing a Ring-Shaped Blood Pressure Monitor in People With Heart FailureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 4 June 2026